UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034896
Receipt number R000039526
Scientific Title Prospective observational study on the clinical course and treatment effect based on QOL evaluation in seasonal influenza
Date of disclosure of the study information 2018/11/15
Last modified on 2018/11/15 10:23:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study on the clinical course and treatment effect based on QOL evaluation in seasonal influenza

Acronym

The QOL study in seasonal influenza

Scientific Title

Prospective observational study on the clinical course and treatment effect based on QOL evaluation in seasonal influenza

Scientific Title:Acronym

The QOL study in seasonal influenza

Region

Japan


Condition

Condition

Seasonal influenza

Classification by specialty

Medicine in general Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To show the clinical course and treatment effect based on QOL evaluation in seasonal influenza

Basic objectives2

Others

Basic objectives -Others

To show whether or not there is a difference between the change of symptoms and that of QOL

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The change of QOL score evaluated by questionnaire

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Influenza patients

Key exclusion criteria

Patients who admitted over 48hours after initiation of symptoms.

Target sample size

55


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yusuke Yoshino

Organization

Teikyo university hospital

Division name

Internal medicine

Zip code


Address

2-11-1, Kaga, Itabashi, Tokyo

TEL

0339641211

Email

yyoshino@med.teikyo-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Yoshino

Organization

Teikyo university hospital

Division name

Internal medicine

Zip code


Address

2-11-1, Kaga, Itabashi, Tokyo

TEL

0339641211

Homepage URL


Email

yyoshino@med.teikyo-u.ac.jp


Sponsor or person

Institute

Department of Internal Medicine, Teikyo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Internal Medicine, Teikyo University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

TUIC-COI 18-0760

Org. issuing International ID_1

Teikyo University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

帝京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 11 Month 15 Day

Date of IRB


Anticipated trial start date

2018 Year 11 Month 15 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 04 Month 30 Day

Date trial data considered complete

2022 Year 05 Month 31 Day

Date analysis concluded

2022 Year 06 Month 30 Day


Other

Other related information

This study is prospective observational study. We plan to evaluate patient's status by using questionnaire.
We plan to ask patients to send their questionnaire by mail or e-mail twice, one and two weeks after the initiation of observation.


Management information

Registered date

2018 Year 11 Month 15 Day

Last modified on

2018 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039526


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name